CD73 apparently participates in tumor immune-escape by inhibiting activation, clonal expansion, and homing of tumor-specific T cells, impairing tumor cell killing and enhancing the conversion of antitumor type 1 macrophages into protumor type 2 macrophages. The gene discussed is NT5E; the disease is neoplasm.